BioSpace News Archive

ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, today announced that Mr. Brendan Brennan, CFO of ICON plc,

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced that it has agreed to acquire Inivata Ltd, a global, commercial stage liquid biopsy platform company headquartered in Cambridge, England.

Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, announces that it has executed an agreement with Takanawa Japan K.K, Pharma Team, for a strategic business development plan to Identify a clinical partner in Japan and other Asian countries for further clinical development of Milciclib for treatment in advanced hepatocellular carcinoma patients.

Alligator Bioscience announced that preclinical data on its agonist anti-CD40 antibody mitazalimab has been published in the scientific journal Cancer Immunology, Immunotherapy.

According to the report, the global orthopedic biomaterials market was valued at US$ 11.3 Bn in 2018 and is projected to expand at a CAGR of ~7% from 2019 to 2027.

The pharmaceutical industry has been experiencing a consistent surge in the past decade, owing to rising prevalence of a number diseases, and biotechnology promises to revolutionize the field going forward.

Transparency Market Research has published a new report titled ‘Global Heart Pumps Market’. According to the report, the global heart pumps market was valued at approximately US$ 1.8 Bn in 2018. The global heart pumps market is expected to expand at a CAGR of ~10% during the forecast period from 2019 to 2027.

According to the report, the global bone growth stimulators market was valued at US$ 1.3 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027.

Rising geriatric population and prohibition of Ritalin and Adderall from competitive sports will boost citicoline market sales.

The anesthesia reversal drugs are used to reverse the effects of sedatives, narcotics, and analgesic drugs when the effects of these drugs are no longer required during and after medical treatment